title: Regulation of mouse p45 NF-E2 transcription by an erythroid-specific GATA-dependent intronic alternative promoter.
abstract: The erythroid-enriched transcription factor NF-E2 is composed of two subunits, p45 and p18, the former of which is mainly expressed in the hematopoietic system. We have isolated and characterized the mouse p45 NF-E2 gene; we show here that, similar to the human gene, the mouse gene has two alternative promoters, which are differentially active during development and in different hematopoietic cells. Transcripts from the distal promoter are present in both erythroid and myeloid cells; however, transcripts from an alternative proximal 1b promoter, lying in the first intron, are abundant in erythroid cells, but barely detectable in myeloid cells. During development, both transcripts are detectable in yolk sac, fetal liver, and bone marrow. Transfection experiments show that proximal promoter 1b has a strong activity in erythroid cells, which is completely dependent on the integrity of a palindromic GATA-1 binding site. In contrast, the distal promoter 1a is not active in this assay. When the promoter 1b is placed 3' to the promoter 1a and reporter gene, in an arrangement that resembles the natural one, it acts as an enhancer to stimulate the activity of the upstream promoter la.
authors.affiliation: Centro di Studio sulla Patologia Cellulare, Consiglio Nazionale delle Ricerche, Istituto di Patologia Generale, Università di Milano, Via Mangiagalli, 31, 20133 Milano, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Moroni
authors.forename: T
authors.initials: T
authors.lastname: Mastrangelo
authors.forename: R
authors.initials: R
authors.lastname: Razzini
authors.forename: L
authors.initials: L
authors.lastname: Cairns
authors.forename: P
authors.initials: P
authors.lastname: Moi
authors.forename: S
authors.initials: S
authors.lastname: Ottolenghi
authors.forename: B
authors.initials: B
authors.lastname: Giglioni
mesh_terms: D017398:Alternative Splicing; D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D004268:DNA-Binding Proteins / Q000235:genetics* / Q000378:metabolism*; D050981:Erythroid-Specific DNA-Binding Factors; D005091:Exons; D005333:Fetus; D050982:GATA1 Transcription Factor; D005786:Gene Expression Regulation; D006801:Humans; D007438:Introns; D046911:Macromolecular Substances; D050985:MafK Transcription Factor; D051379:Mice; D008969:Molecular Sequence Data; D050983:NF-E2 Transcription Factor; D050984:NF-E2 Transcription Factor, p45 Subunit; D009687:Nuclear Proteins / Q000235:genetics; D011401:Promoter Regions, Genetic; D016415:Sequence Alignment; D012689:Sequence Homology, Nucleic Acid; D014157:Transcription Factors / Q000235:genetics* / Q000378:metabolism*; D014158:Transcription, Genetic
chemical_list: D004268:DNA-Binding Proteins; D050981:Erythroid-Specific DNA-Binding Factors; D050982:GATA1 Transcription Factor; C494688:GATA1 protein, human; C494689:Gata1 protein, mouse; D046911:Macromolecular Substances; D050985:MafK Transcription Factor; C494696:Mafk protein, mouse; D050983:NF-E2 Transcription Factor; D050984:NF-E2 Transcription Factor, p45 Subunit; C494692:NFE2 protein, human; C494693:Nfe2 protein, mouse; D009687:Nuclear Proteins; D014157:Transcription Factors